Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/23/16 20:12 | 3/23/16 | HTBX | Health | Drug | Pharmaceutical Preparations | Kharitonov Michael | NC | D | P.d | 675 | 0.7500 | 1 | 900 | 999% | 950 | D | -90 | -90 | -88 | -68 | -67 | -30 | -14 | -64 | 3 | 0 | -8 | -13 | 100 | 48 | |
6/6/14 09:01 | 6/5/14 | HTBX | Health | Drug | Pharmaceutical Preparations | Price Melissa | NC | O | VP Clini | P | 3 | 4.30 | 0 | 1 | New | 1 | I | -45 | -38 | -27 | 7 | -7 | -6 | 1 | 8 | 23 | 55 | 8 | 54 | ||
5/20/14 14:16 | 5/19/14 | HTBX | Health | Drug | Pharmaceutical Preparations | Wolf Jeffrey Alan | NC | DOT | CEO | P | 10 | 4.13 | 0 | 3 | 0 | 1,236 | D | -52 | -52 | -34 | -26 | -8 | -1 | 3 | 13 | 22 | 7 | 10 | 43 | ||
5/16/14 17:00 | 5/16/14 | HTBX | Health | Drug | Pharmaceutical Preparations | Belsky Paul | NC | D | P | 10 | 4.11 | 0 | 3 | 6 | 47 | D | -52 | -54 | -42 | -30 | -18 | -4 | 2 | 20 | 25 | -1 | 27 | 46 | |||
7/29/13 12:25 | 7/29/13 | HTBX | Health | Drug | Pharmaceutical Preparations | Wolf Jeffrey Alan | NC | DOT | CEO | P.d | 0 | 0.00 | 4 | 0 | 0 | 1,234 | D | -1 | 9 | 8 | 11 | -18 | -56 | ||||||||
7/29/13 12:15 | 7/29/13 | HTBX | Health | Drug | Pharmaceutical Preparations | Belsky Paul | NC | D | P.d | 0 | 0.00 | 4 | 0 | 0 | 45 | D | -1 | 9 | 8 | 11 | -18 | -56 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |